Abstract
Erythropoietin is recognized as a pluripotent glycoprotein with unique biochemical and epigenetic properties that are important for fetal growth and development, as well as in critical conditions in subsequent periods of ontogenesis. In recent decades, researchers and clinicians have increased interest in the problem of the biological significance of erythropoietin, which can form the basis for constructing algorithms for early prognosis and diagnosis, optimizing the treatment of pathology of the perinatal period, including perinatal hypoxic-ischemic damage to the brain and spinal cord, which are at risk of disability and have a risk of disability significant role in neonatology and perinatal neurology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
